Announcements Trials
Browse Landscape

Phase

Phase NA 86Phase 2 77Phase 1 43Phase 1/2 33Phase EARLY_PHASE1 13Phase 3 9Phase 2/3 5Phase 4 3

Status

Recruiting 154Completed 107Not yet recruiting 65Active not recruiting 60Terminated 14Enrolling by invitation 9Withdrawn 3Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Pelvic Pain 1Opioid-Related Disorders 1Metrorrhagia 1Menorrhagia 1Melanoma 1Lymphoma, Follicular 1Leiomyoma 1

Interventions

encorafenib 1binimetinib 1Buprenorphine, Naloxone Drug Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Withdrawn × 1 year × Clear all
NCT07092410 2026-04-21

SuRage-EB

SRH Wald-Klinikum Gera GmbH

Phase 4 Withdrawn
Dermatologic

Melanoma

NCT04091009 2025-12-31

Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms

Massachusetts General Hospital

Phase 4 Withdrawn
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

NCT05538689 2025-09-29

SOUL

University of Chicago

Phase 4 Withdrawn

Leiomyoma, Menorrhagia, Metrorrhagia, Pelvic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡